Elidah Launches Novel Research Study on At-home Treatment for Urinary Incontinence in Men

The study aims to help men post-prostatectomy with leaky bladders and sexual function.
Elidah, a pioneer in healthcare technology known for its FDA-cleared non-invasive, wearable urinary incontinence treatment for women, recently launched a novel at-home research study targeting urinary incontinence in men.

This study focuses on men who are scheduled for or have undergone robotic-assisted laparoscopic prostatectomy and are experiencing incontinence, as up to 60% [https://pubmed.ncbi.nlm.nih.gov/19233390/] of men face persistent urinary incontinence after this procedure, significantly impacting their quality of life. With about 233,000 [https://pubmed.ncbi.nlm.nih.gov/30207593/] new cases of prostate cancer diagnosed annually in the U.S., effective control of side effects like incontinence is crucial for improving the quality of life of prostate cancer survivors. This innovative study addresses a significant unmet need in men's health, providing a potential solution for millions.

"Although urinary incontinence in women is more common, every day we get many requests for a similar device for men since the launch of Elitone [https://elitone.com]," said Gloria Kolb, CEO of Elidah. "We are thrilled to be at the forefront of developing a solution that not only improves physical health but also restores confidence and quality of life for men."

Studies [https://www.nejm.org/doi/full/10.1056/NEJMoa1606221] indicate that nearly half of men continue to use pads six months after prostate surgery. This research aims to evaluate the effectiveness of Elidah's wearable treatment device in reducing incontinence, decreasing pad use, and accelerating the recovery of sexual function and confidence. The male device is identical to Elitone except for a male-anatomy shaped GelPad. The design of the male GelPad had been funded by the Department of Defense.

Why This Study is Novel:

*
Unique Approach: This study is among the first of its kind, with an aim to strengthen the pelvic floor muscles for men with a non-invasive, wearable device.

*
Neuromuscular Stimulation: The device uses neuromuscular stimulation through a male-shaped GelPad applied to the perineum.

*
Ease of Use: Treatment requires only 20 minutes per day, and is worn under clothes, allowing participants to integrate it seamlessly into their daily routines.

Elidah is still recruiting participants for their study who are scheduled for or had robotic-assisted laparoscopic prostatectomy and struggle with incontinence.

For more information on this research study or to join, please visit https://elitone.com/clinical-study/ [https://elitone.com/clinical-study/].

About Elidah

Elidah, a medical equipment manufacturer, serves as a health leader in incontinence treatment for the home. Elitone devices are recognized as the first and only non-intrusive treatment for stress, mixed, and urge bladder leaks. It remains non-intrusive both physically and in terms of time, allowing individuals to undergo treatment while engaging in other tasks. The devices are specifically designed to address the common issue of bladder leaks, whether occurring during sneezing and coughing or due to the urgency of an overactive bladder.

Media Contact
Company Name: OtterPR
Contact Person: Pilar Lewis
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=elidah-launches-novel-research-study-on-athome-treatment-for-urinary-incontinence-in-men]
Address:320 1st Ave N
City: St. Petersburg
State: Florida
Country: United States
Website: http://OtterPR.com



This release was published on openPR.